Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014;13(5):679-80.
doi: 10.4161/cc.27853. Epub 2014 Jan 21.

Skp2: a dream target in the coming age of cancer therapy

Affiliations
Editorial

Skp2: a dream target in the coming age of cancer therapy

Chia-Hsin Chan et al. Cell Cycle. 2014.
No abstract available

Keywords: Skp2 inhibitor; cancer stem cells; cancer therapy; cell cycle arrest; glycolysis; in silico modeling; senescence.

PubMed Disclaimer

Figures

None
Figure 1. Potential applications of Skp2 inhibitor compound #25. The current study identifies a specific Skp2 inhibitor compound #25 that phenocopies the effect of Skp2 deficiency to target tumorigenesis by upregulation of p27 tumor suppressor and inactivation of Akt oncoprotein. Given that Skp2 loss reduces the number of adipocytes, possibly through p27 accumulation, compound #25 may also be used as a tool for obesity prevention.

Comment on

References

    1. Hershko DD. Cancer. 2008;112:1415–24. doi: 10.1002/cncr.23317. - DOI - PubMed
    1. Chen Q, et al. Blood. 2008;111:4690–9. doi: 10.1182/blood-2007-09-112904. - DOI - PMC - PubMed
    1. Wu L, et al. Chem Biol. 2012;19:1515–24. doi: 10.1016/j.chembiol.2012.09.015. - DOI - PMC - PubMed
    1. Chan CH, et al. Cell. 2012;149:1098–111. doi: 10.1016/j.cell.2012.02.065. - DOI - PMC - PubMed
    1. Chan CH, et al. Cell. 2013;154:556–68. doi: 10.1016/j.cell.2013.06.048. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources